ITGAM and neoplasm: We found that LA1, a potent activator of integrin CD11b/CD18 in vitro and in vivo42, could significantly alter macrophage polarization, increase CD8+ T cell recruitment to tumors, inhibit tumor progression and prolong survival in mouse models of cancer.